Drug: panitumumab Injury: Peripheral sensory neuropathy Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
88186503 | PANITUMUMAB | Peripheral sensory neuropathy | ROCHE | 0.00 | 0 | 20160913 | DK | |
122329126 | panitumumab | Peripheral sensory neuropathy | AMGEN | 59.00 YR | M | 66 KG | 20160811 | JP |
123861304 | panitumumab | Peripheral sensory neuropathy | AMGEN | 0.00 | M | 80 KG | 20160813 | JP |
124904633 | panitumumab | Peripheral sensory neuropathy | AMGEN | 0.00 | F | 55 KG | 20160711 | JP |
125383402 | panitumumab | Peripheral sensory neuropathy | AMGEN | 0.00 | F | 59 KG | 20160909 | JP |
126918812 | panitumumab | Peripheral sensory neuropathy | AMGEN | 65.00 YR | M | 69 KG | 20160906 | JP |
127567761 | panitumumab | Peripheral sensory neuropathy | AMGEN | 66.00 YR | M | 61 KG | 20160917 | JP |
1185397513 | panitumumab | Peripheral sensory neuropathy | AMGEN | 76.00 YR | M | 53 KG | 20160917 | JP |
Total Records: 8 Number of Pages: 1